- Home
- LGND vs ESRT Comparison
LGND vs ESRT Comparison
Compare LGND & ESRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGND
- ESRT
- Stock Information
- Founded
- LGND 1987
- ESRT 2011
- Country
- LGND United States
- ESRT United States
- Employees
- LGND N/A
- ESRT N/A
- Industry
- LGND Biotechnology: Pharmaceutical Preparations
- ESRT Real Estate Investment Trusts
- Sector
- LGND Health Care
- ESRT Real Estate
- Exchange
- LGND Nasdaq
- ESRT Nasdaq
- Market Cap
- LGND 2.0B
- ESRT 1.8B
- IPO Year
- LGND 1992
- ESRT 2013
- Fundamental
- Price
- LGND $111.71
- ESRT $10.60
- Analyst Decision
- LGND Strong Buy
- ESRT Hold
- Analyst Count
- LGND 6
- ESRT 3
- Target Price
- LGND $144.83
- ESRT $10.67
- AVG Volume (30 Days)
- LGND 142.9K
- ESRT 1.2M
- Earning Date
- LGND 11-07-2024
- ESRT 10-21-2024
- Dividend Yield
- LGND N/A
- ESRT 1.32%
- EPS Growth
- LGND 160.46
- ESRT N/A
- EPS
- LGND 2.47
- ESRT 0.27
- Revenue
- LGND $152,422,000.00
- ESRT $763,203,000.00
- Revenue This Year
- LGND $23.19
- ESRT N/A
- Revenue Next Year
- LGND $15.08
- ESRT $2.20
- P/E Ratio
- LGND $45.20
- ESRT $38.80
- Revenue Growth
- LGND N/A
- ESRT 4.84
- 52 Week Low
- LGND $57.00
- ESRT $8.39
- 52 Week High
- LGND $129.90
- ESRT $11.62
- Technical
- Relative Strength Index (RSI)
- LGND 48.80
- ESRT 41.98
- Support Level
- LGND $119.69
- ESRT $10.76
- Resistance Level
- LGND $125.76
- ESRT $11.01
- Average True Range (ATR)
- LGND 5.73
- ESRT 0.24
- MACD
- LGND -0.30
- ESRT -0.03
- Stochastic Oscillator
- LGND 25.51
- ESRT 19.14
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About ESRT Empire State Realty Trust Inc.
Empire State Realty Trust operates as a pure-play greater New York and Manhattan-focused REIT, featuring its landmark Empire State Building office and observation deck. The company owns and operates around 8.5 million square feet of office space, about 80% of which is located in Manhattan.